markets
Pharma Stocks Rally: Two to Buy, Two to Avoid, According to Barron's
Source: Barron's
Barron's reports on the recent rally in pharma stocks, identifying two specific stocks to buy and two to avoid based on their analysis.
Pharma stocks have experienced a rally, with Barron's identifying specific recommendations for investors. According to a report from Barron's published on August 21, 2026, the financial publication highlighted two pharmaceutical stocks that it suggests investors buy, alongside two other pharma stocks that it recommends avoiding. For readers following broader market updates , this development can help frame the wider news context.
Read original source